Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America et al v. Diabetic Care Rx, LLC et al
-
March 16, 2018
Private Equity FCA Suit More Likely Outlier Than Omen
The U.S. Department of Justice's unusual decision to name a private equity firm as a defendant in a False Claims Act suit against one of the firm's portfolio companies is an issue all private equity firms should be aware of, although the alleged circumstances of the case may mean similar complaints will be few and far between, attorneys say.
-
February 23, 2018
US Steps Into Tricare FCA Suit Against Pharmacy, PE Owner
The government has intervened in a False Claims Act suit accusing a Florida compounding pharmacy and its private equity fund owner of running a kickback scheme that induced Tricare to pay more than $68 million for medically unnecessary prescriptions, the U.S. Department of Justice announced Friday.
- ← Previous
- 1
- 2
- Next →